MPM BioVentures 2018 GP LLC, 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 293,370 shares at $43.20 ($12.5M) on 2022-01-04, disclosed to the SEC on 2022-01-06.
Open-market sale of $12.5M ITOS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.05 | 94,745 | $4.0M | 31.9% |
| 2 | $42.05 | 94,745 | $4.0M | 31.9% |
| 3 | $43.20 | 19,366 | $837K | 6.7% |
| 4 | $43.20 | 19,366 | $837K | 6.7% |
| 5 | $45.32 | 6,768 | $307K | 2.5% |
| 6 | $45.32 | 6,768 |
| $307K |
| 2.5% |
| 7 | $46.47 | 7,671 | $356K | 2.9% |
| 8 | $46.47 | 7,671 | $356K | 2.9% |
| 9 | $42.03 | 18,135 | $762K | 6.1% |
| 10 | $42.03 | 18,135 | $762K | 6.1% |
| Total | $42.58 avg | 293,370 | $12.5M | 100% |
| Filing → |
| ITOS | SELL | 2021-10-18 | $939K | — | Filing → |
| ITOS | SELL | 2021-10-14 | $2.3M | — | Filing → |
| ITOS | SELL | 2021-09-30 | $581K | — | Filing → |